◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Nippon Shinyaku Co., Ltd. (4516) Financial History

Name: Nippon Shinyaku Co., Ltd. (4516) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Nippon Shinyaku Co., Ltd. (4516) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kyoto, Japan with about 2,309 employees. Its market capitalization is roughly JPY 242 billion. In the fiscal year ended 2026-03-31, 4516 reported JPY 170.8B in revenue and JPY 29.7B in net income.

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments.

Interactive charts & full statements →

4516 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 170.8B	JPY 160.2B	JPY 148.3B	JPY 144.2B
Gross Profit	JPY 113.3B	JPY 109.1B	JPY 98.0B	JPY 88.2B
Operating Income (EBIT)	JPY 35.5B	JPY 35.5B	JPY 33.3B	JPY 30.1B
Net Income	JPY 29.7B	JPY 32.6B	JPY 25.9B	JPY 22.8B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4516 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 8.4B)	(JPY 8.3B)	(JPY 8.0B)	(JPY 7.8B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4516 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 346.4B	JPY 283.6B	JPY 263.4B	JPY 237.5B
Total Liabilities	JPY 54.5B	JPY 36.3B	JPY 42.9B	JPY 41.5B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4516 viewer.

4516 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4151 · Kyowa Kirin Co., Ltd. — $1.34 trillion
4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion
4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4512 All “0-9” companies 4519 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.